The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
Open accessAbstract
The mechanism by which pharmacologic administration of the hormone FGF21 increases energy expenditure to cause weight loss in obese animals is unknown. Here we report that FGF21 acts centrally to exert its effects on energy expenditure and body weight in obese mice. Using tissue-specific knockout mice, we show that βKlotho, the obligate coreceptor for FGF21, is required in the nervous system for these effects. FGF21 stimulates sympathetic nerve activity to brown adipose tissue through a mechanism that depends on the neuropeptide corticotropin-releasing factor. Our findings provide an unexpected mechanistic explanation for the strong pharmacologic effects of FGF21 on energy expenditure and weight loss in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss likely occurs [163,165] at the expense of VAT, as evidenced by a 15% mean decrease in abdominal fat content, measured by DEXA, in obese monkeys [165].”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [163]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FGF21 further augments BAT function indirectly, by increasing SNS output [163,165] (7)”
In the citing paper
“These effects of extended FGF21 signalling in promoting weight loss through increased energy expenditure are mediated through direct actions on the central nervous system67,80–84, not adipose tissues65,67,85”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“Instead, FGF21 signals directly to the CNS (Fig. 3a), at least in rodents, and consequently regulates energy expenditure and improves glucose and lipid homeostasis80,82.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“while it signals the CNS to increase energy expenditure and decrease body weight [169,171,172] (Figure 2).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [172]
In the citing paper
“The chronic metabolic effects of FGF21 on body weight and glucose homeostasis are lost when β-klotho is deleted from the CNS (Klbfl/fl;Camk2a-Cre) (101, 126).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“FGF21 administration increases sympathetic nerve activity to BAT (101) and WAT (28), and browning of WAT depots (28, 101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“The administration of a corticotropin-releasing hormone antagonist blocks FGF21-mediated increases in sympathetic nerve activity to BAT (101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“Interestingly, FGF21-mediated increases in sympathetic nerve activity to BAT appear to require hypothalamic corticotropin-releasing hormone.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478 · cited 8×
“FGF21 also promotes the browning of scWAT (Fisher et al., 2012), an effect that in vivo involves bKlotho in the nervous system.”
InfluentialXu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Self-citationLin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691
BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
Whittle, A. J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M. J., Morgan, D., Csikasz, R. I., Gallego, R., Rodriguez-Cuenca, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.066 · Cited by 573
Self-citation
Cited by
Sorted by citations
Items 401–500 of 519
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
Saavedra, L. P. J., Raposo, S. R., Assakawa, A. L. M., Lucredi, N. C., Peres, M. N. C., Piovan, S., Gonçalves, G. D., Moreira, V. M., Barbosa, L. F., Sousa, D., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118166 · Cited by 4
Meng, J., Chen, X., & Zhu, Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf176 · Cited by 4
Spann, R. A., Kim, S. Q., Khan, M. S. H., Albarado, D. A., Fernandez‐Kim, S. O., Berthoud, H., McDougal, D. H., Münzberg, H., He, Y., Yu, S., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117218 · Cited by 4
The role of β-Klotho in FGF signaling: from molecular insights to therapeutic innovations
Yan, F., Yang, C., Huang, S., Yuan, L., Qiu, Y., Liu, T., Peng, X., & Yang, Y. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2026 · Cited by 4
Shen, Y., Zhu, Z., Wang, Y., Qian, S., Xu, C., & Zhang, B. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06709-3 · Cited by 4
Saponins from Panax japonicus Enhance Lipolysis via Acting on FGF21-β-Klotho/FGFR1 in Obese Mice
Wang, T., Huang, Y., Hu, M., Huang, X., Yu, D., Jia, L., Zhi, W., Mu, Y., Zhou, Z., & Wang, J. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c01012 · Cited by 4
Matsui, M., Kosaki, K., Kuro‐o, M., Saito, C., Yamagata, K., & Maeda, S. (2021) · Hypertension Research · doi:10.1038/s41440-021-00782-3 · Cited by 4
Pedersen, A. K. N., Hage, C., Jessen, N., Mellbin, L., & Bjerre, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111738 · Cited by 4
Biomonitoring and Digital Data Technology as an Opportunity for Enhancing Animal Study Translation
Defensor, E. B., Lim, M. A., & Schaevitz, L. R. (2021) · ILAR Journal · doi:10.1093/ilar/ilab018 · Cited by 4
FGF-21 Conducts a Liver-Brain-Kidney Axis to Promote Renal Cell CarcinomaPreprint
Li, Z., Zhang, X., Zhu, W., Zhang, C., Sadak, K., Halberstam, A. A., Brown, J. R., Perry, C. J., Bunn, A., Braun, D. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.12.536558 · Cited by 5
Norlin, J., Dermit, M., Sidiropoulos, N., Galsgaard, E. D., Hansen, H. H., Feigh, M., Veidal, S. S., Latta, M. R., Henriksson, E., & Andersen, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331665 · Cited by 3
MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes
Nishio, M., Yamaguchi, K., Otani, J., Yuguchi, K., Kohno, D., Sasaki, T., Kitamura, T., Shinohara, M., Soga, T., Kawamura, K., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424741122 · Cited by 3
Hashimoto, N., Nagata, R., Han, K., Wakagi, M., Ishikawa-Takano, Y., & Fukushima, M. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00987-9 · Cited by 3
Jain, U., Srivastava, P., Sharma, A., Sinha, S., & Johari, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998265915231116043813 · Cited by 3
Kundimi, S., Chinta, G., Alluri, K. V., Golakoti, T., Veeramachaneni, S., Ramanathan, G., & Sengupta, K. (2023) · Journal of the American Nutrition Association · doi:10.1080/27697061.2023.2280777 · Cited by 3
Matta, R., El-Hini, S. H., Saad, M., Mostafa, H., & AbedelfadeeL, A. (2017) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/ejode.ejode_30_16 · Cited by 3
Buss, N. A. P. S., Lapointe, J., de Haan, L., Price, S. R., Ahnmark, A., Irving, L. M., Buchanan, A. G., Keyes, F., Davidsson, P., Dixit, R., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.033 · Cited by 3
Díaz-Catalán, D., Capó, J., Vega‐Beyhart, A., Rodrigo‐Calvo, M. T., Mora, M., Vidal, Ó., Squarcia, M., Enseñat, J., Casals, G., & Hanzu, F. A. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102122 · Cited by 2
Lail, H. L., Lawrence, R. C., Pinheiro, F., Price, E., & Wanders, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343503 · Cited by 2
Brunel, F. M., Parlee, S. D., Li, P., Lu, W., Chabenne, J. R., Pérez–Tilve, D., Finan, B., Kharitonenkov, A., & DiMarchi, R. D. (2026) · Biochemistry · doi:10.1021/acs.biochem.5c00820 · Cited by 2
Lin, Y., Claflin, K. E., Aklan, İ., Morgan, D. A., Sullivan, A. I., Rudolph, M. C., Rahmouni, K., & Potthoff, M. J. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117093 · Cited by 3
Self-citationYoshida, Y., Oikawa, M., Shimada, T., Shinomiya, A., & Watanabe, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.07.041 · Cited by 2
Multiomics unravels the complexity of male obesity: a prospective observational study
Papadakis, G. E., Favre, L., Zouaghi, Y., Vionnet, N., Niederländer, N. J., Adamo, M., Acierno, J. S., Berdous, D., Boizot, A., Meylan, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06040-7 · Cited by 2
Galsgaard, K. D., Elmelund, E., Hunt, J. E., Smits, M. M., Grevengoed, T. J., Christoffersen, C., Færgeman, N. J., Havelund, J. F., Albrechtsen, N. J. W., & Holst, J. J. (2025) · Physiological Reports · doi:10.14814/phy2.70235 · Cited by 2
Research progress of fibroblast growth factor in nervous system diseases
Huang, W., Wan-hua, Q., Chen, K., Ye, S., Wang, D., HU, J. L., Xu, H., Lin, L., & Xiaokun, L. I. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0180 · Cited by 2
Endocrine fibroblast growth factors and Klotho
Kuro‐o, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818036-5.00007-0 · Cited by 2
Matsui, M., Kosaki, K., Akazawa, N., Tanahashi, K., Kuro‐o, M., & Maeda, S. (2019) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.8.195 · Cited by 2
Jezdimirović, T., Štajer, V., & Ostojić, S. M. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1683586 · Cited by 2
FGF21 Attenuates Neurodegeneration though Modulating Neuroinflammation and Oxidant-stressPreprint
Kang, K., Xu, P., Wang, M., Chunyu, J., Sun, X., Ren, G., Xiao, W. L., & li, D. (2020) · doi:10.21203/rs.2.17629/v2 · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00003-2 · Cited by 2
Chemogenetic activation of hepatic G12 signaling ameliorates hepatic steatosis and obesity
Arai, K., Ono, Y., Hirai, N., Sugiura, Y., Kaneko, K., Matsuda, S., Iio, K., Kajino, K., Saitoh, T., Wei, F., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167566 · Cited by 1
Rajendiran, R., Pathak, S., Kumar, A., Bhaumik, S., Amit, S., Pydi, S. P., & Jayandharan, G. R. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01896 · Cited by 1
Holleboom, A. G., & Schattenberg, J. M. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101957 · Cited by 1
Yang, C., Chen, L., Xiao, H., Wei, W., Liang, J., Chen, T., Yang, T., & Ma, Y. (2026) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70113 · Cited by 1
Wali, J. A., Ramos-Nieves, J. M., Binia, A., & van der Beek, E. M. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100713 · Cited by 1
Overexpression and biophysical and functional characterization of a recombinant FGF21
Phan, P., Hoang, J., & Kumar, T. K. S. (2025) · Biophysical Reports · doi:10.1016/j.bpr.2025.100198 · Cited by 1
Helvacıoğlu, S., Cools, B., Ong, J., Waisberg, E., Lee, R. S., Lee, A. G., & Vinken, M. (2025) · Life Sciences in Space Research · doi:10.1016/j.lssr.2025.07.001 · Cited by 1
Shi, F., Yang, Z., Zhang, L., Zou, D., Yu, J., Guo, N., Ren, S., Tang, X., Gu, C. J., Xu, R., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02233-4 · Cited by 1
Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease
Tanaka, T., Suda, G., Ohara, M., Maehara, O., Yoda, T., Fu, Q., Yang, Z., Yasuura, N., Meno, A., Sasaki, T., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1730695 · Cited by 1
Jiménez, V., Sacristan, V., García, M., Jambrina, C., Casana, E., MUÑOZ, S. A., Vilà, L., Grass, I., Jaén, M. L., Roca, C., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.025 · Cited by 2
Mansouri, F., Nikooie, R., Mehrtash, M., & Hamidi, M. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112864 · Cited by 2
Environmental and Physiological Cues on the Hypothalamus During Aging
Nehlin, J. O. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_9 · Cited by 1
Cold environments and human metabolism: A traditional chinese medicine perspective
Zhao, T., Ma, Y., Zhang, J., Zhou, X., Zhou, Y., & Yan, J. (2024) · Frigid Zone Medicine · doi:10.1515/fzm-2024-0009 · Cited by 1
Intercepting Modes of Cellular Communication
Claflin, K. E., & Potthoff, M. J. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101531 · Cited by 1
FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
Whittle, A. J. (2016) · Endocrinology · doi:10.1210/en.2016-1193 · Cited by 1
Xu, Y., & Pan, J. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100252 · Cited by 1
The Metabolic Effects of FGF21: From Physiology to Pharmacology
Song, P. (2020) · JoLS Journal of Life Sciences · doi:10.5352/jls.2020.30.7.640 · Cited by 1
Trefts, E. (2019) · Cited by 1
Neural afferents as potential targets to ameliorate FGF21-mediated sympathoexcitation
Katsurada, K., & Kario, K. (2021) · Hypertension Research · doi:10.1038/s41440-021-00811-1 · Cited by 1
SUMOylation of ABCD3 restricts bile acid synthesis and regulates metabolic homeostasisPreprint
Goyon, V., Besse‐Patin, A., Zunino, R., Nguyen, M., Coyaud, É., Lee, J. M., Nguyen, B., Raught, B., & McBride, H. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482848 · Cited by 1
FGF21 Counteracts Adipose Tissue Wasting in Cancer-Associated CachexiaPreprint
Österreicher, T., Kührer, K., Höbler, A.-L., Berghoff, A. S., Gottmann, L., Udonta, F., Körbelin, J., Pollak, D. D., Hengstschläger, M., Loges, S., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4896832 · Cited by 1
Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
Akie, T. E. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2388v
Molecular Nutrition Study of the Transcriptional Regulation of Anti-obesity Hormones
Shimizu, M. (2016) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.69.277
LaPierre, M. P. (2015) · TSpace (University of Toronto)
Fu, X., Tao, M., Ma, H., Wang, C., Li, Y., Hu, X., Qin, X., Lv, R., Zhou, G., Wang, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/869644
Lee, S. Y. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136835
Rôle des hépatokines dans le dialogue inter-organes en physiologie et physiopathologie
Pacheco, A., & Postic, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.04.008
Melaku, L. S., & Debela, N. (2020) · Indian Journal of Health Sciences and Biomedical Research (KLEU) · doi:10.4103/kleuhsj.kleuhsj_92_20
Anxiety Induced by Extra-Hypothalamic BDNF Deficiency Instigates Resistance to Diet-Induced ObesityPreprint
Xie, X., Yang, H., An, J. J., Liao, G., Xu, Z., Tan, J., & Xu, B. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3188489
前島精治 (2005) · 日本皮膚科学会雑誌
Yunker, A. G., Alves, J. M., LUO, S. H., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Jann, K., Monterosso, J. R., & Page, K. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.29.446318
Developmental signaling pathways in adult energy homeostasis
Antonellis, P. J. (2021) · Figshare · doi:10.25394/pgs.15062292.v1
Ladbury, J. E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737907472.793574673
Kalra, S., Singla, R., Rosha, R., Dhawan, M., Priya, G., Priya, G., & Dutta, D. (2018) · US Endocrinology · doi:10.17925/use.2018.14.2.59
Role of Taurine Supplementation in Obesity: Stimulating Fats to Burn in Cellular Power Plants
Heidari, R., & Ommati, M. M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124484123010013
Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesityPreprint
Chitraju, C., Fischer, A. W., Ambaw, Y. A., Wang, K., Yuan, B., Hui, S. T., Walther, T. C., & Farese, R. V. (2023) · eLife · doi:10.7554/elife.88049.1
Walther, T. C., Chitraju, C., Fischer, A. W., Ambaw, Y. A., Wang, K., Yuan, B., Hui, S. T., & Farese, R. V. (2023) · eLife · doi:10.7554/elife.88049.3.sa4
Central Control of Glucose Homeostasis
Alonge, K. M., Francis, K. L., Richardson, N. E., & Schwartz, M. W. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch10
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00009-3
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00000-7
Бажан, Н. М., & En, M. (2023) · Успехи физиологических наук · doi:10.31857/s0301179823040033
Alieva, A. M., Teplova, N. V., Reznik, E. V., Baykova, I. E., Khadzhieva, N. K., Voronkova, K. V., Kovtyukh, I. V., Valiev, R. K., Kotikova, I. A., & Nikitin, I. G. (2024) · Consilium Medicum · doi:10.26442/20751753.2024.1.202593
Mirhoseini, M., Eslamian, G., Ghorbani, A., Zand, H., & Vasheghani‐Farahani, E. (2024) · Iṭṭilā’āt-i māhiyānah. · doi:10.61186/nsft.19.2.1
Yoshida, Y., Shinomiya, A., Oikawa, M., Shimada, T., Hanaki, K., & Watanabe, Y. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00177-3
Insulin-sensitizing effects of fibroblast growth factor-21 in underfed sheep
dos Santos, A. C. R., McGuckin, M. M., Giesy, S. L., & Boisclair, Y. R. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf217
Dong, Z., Li, L., Huo, M., Zhang, Y., Zhou, X., Tang, M., Peng, Z., Cui, W., Liu, J., Wang, J., et al. (2025) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-1249
FGF21 and the brain-liver axis: Harnessing sympathetic pathways in MASH
Marjot, T. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.026
Yoshida, Y., Shinomiya, A., Hanaki, K., & Watanabe, Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152874
Kishimoto, T., Nasu, A., Uemura, M., Kawano, K., Ogasawara, C., Fukuyama, A., Nohara, H., Nakashima, R., TAKAHASHI, N., Fujiwara, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25705-x
Chen, Z., Xu, M., Chen, S., & Chen, L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110977
NOVEL APPROACHES IN OBESITY TREATMENT: THE PROMISE OF GENE THERAPIES
Błądzińska, K., Opalińska, A., Lubas, C., Folta, P., Szeląg, K., Kłosowska, J., Błądziński, M., Zach, M., Świerczek, P., & Kujawski, A. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4362
Liu, L., Ning, N., Xu, S., Chen, D., Zhou, L., Guo, Z., Liang, X., & Ye, X. (2024) · Figshare · doi:10.6084/m9.figshare.26733019
Effects of Perga on FGF21/Leptin/Insulin in Imparied Glucose Regulation
Acun, A. D., Afşar, E., Aslan, E., & Uslu, S. (2025) · Journal of Research in Veterinary Medicine · doi:10.30782/jrvm.1703629
Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers
Moriyama, K. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i1.112821
Rusu, P. M., Aung, O. H., Chan, A. Y., Wu, Y., Cleofe, M. A. S., Trewin, A. J., Giri, S., Foollee, A., flores, S., Lemus, M. B., et al. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101132
The fibroblast growth factor-Klotho endocrine system in health and disease
Makoto, K.-O. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00034-7
Hypothalamus-liver talks: whispers in the language of metabolism
Ferreira, V., Fernández-González, I., Vattathara, J. J., Rodríguez-Díaz, A., Fernández-Sanmartín, P., & Diéguez, C. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10031-y
Zhu, R. Y., Wang, X., Ma, J., Shi, X., Zhang, Y., Jin, J., & Zhou, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1598164
Rôle des aminoacides ramifiés dans le déterminisme génétique de la résistance à l’insuline
Haydar, S. (2018) · theses.fr (ABES) · doi:10.70675/5c14c2c4z469bz40fazb55cz985ea78d6c2a
Metadata
- Authors
- Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., Kliewer, S. A., & Mangelsdorf, D. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Kliewer, Steven A.
- Mangelsdorf, David J.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 20
- Issue
- 4
- Pages
- 670-677
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4192037
- OpenAlex
- W2158477352
- Cited by
- 523
- References
- 45
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 40 · 2023: 43 · 2022: 49 · 2021: 38 · 2020: 49 · 2019: 46 · 2018: 50 · 2017: 44 · 2016: 39 · 2015: 47 · 2014: 3
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1F32DK098908, GM007062, HL084207, R01DK067158)
- Howard Hughes Medical Institute
- Welch Foundation (I-1275, I-1558)
- American Heart Association (14EIA18860041)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- FGF21, β-Klotho, central nervous system, sympathetic activity, brown adipose tissue, energy expenditure, weight loss, corticotropin-releasing factor, obesity, tissue-specific knockout mice
- MeSH terms
- Klotho Proteins, Animals, Adipose Tissue, Brown, Corticotropin-Releasing Hormone, Energy Metabolism, Fibroblast Growth Factors, Hypothalamus, Membrane Proteins, Mice, Inbred C57BL, Mice, Obese, Mice, Transgenic, RNA, Messenger, Sympathetic Nervous System, Weight Loss, Mice, Knockout, Thermogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
